A Multi-center Long Term Efficacy Trial of the GFX For Reduction of Glabellar Furrowing

Completed · Phase 4

Conditions studied: Glabellar Furrowing

In brief

Long term efficacy study of GFX for patients undergoing reduction of glabellar furrowing

Key facts

Study ID

NCT00611273

Run by

Advanced Cosmetic Intervention

People needed

260

Starts

2007-09-01

Expected to finish

2008-04-01

Last updated by the study team

2014-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Paul S. Nassif, MD, FACS — Beverly Hills, California, United States
• James Newman — San Mateo, California, United States
• Michael E. Jansin, MD — Tampa, Florida, United States
• Foad Nahai, M.D., F.A.C.S. — Atlanta, Georgia, United States
• Steven P. Block, MD — Highland Park, Illinois, United States
• Keith LaFerriere, MD — Springfield, Missouri, United States
• J. Smythe Rich, III, M.D — Columbia, South Carolina, United States
• Russell W. Kridel, MD — Houston, Texas, United States
• Roger C. Mixter, MD — Milwaukee, Wisconsin, United States
• David A. Ellis, MD — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.